EXHIBITION PREVIEW
Commercial support for the BSMT Annual Microbiology Conference
As always, the 41st Annual Microbiology Conference, hosted by the British Society for Microbial Technology (BSMT) will be supported by a trade exhibition. Here, Pathology in Practice previews the companies which will be present.
Becton Dickinson UK BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics
BioConnections.
and therapeutics. BD has a presence in virtually every country and partners with organisations around the world to address some of the most challenging global health issues. By working in close collaboration
with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
www.bd.com/en-uk
BioConnections Have you ever had to prepare your own control? If so, what did you use – was it a live culture? Sifin control antigens are designed
Becton Dickinson UK.
to make life in the laboratory easier and more efficient. They are ready to use, eliminating the need for time-consuming culture preparation, reducing waste, and offering an extended shelf life. With the transition to ISO 15189:2022,
laboratories are now required to take a proactive approach to identifying risks
44
WWW.PATHOLOGYINPRACTICE.COM April 2026
and opportunities for improving systems and processes. One effective way to meet these requirements is through the use of third-party controls. The benefits are clear: improved standardisation and reliability, reduced workflow variability, enhanced assay reproducibility, and greater diagnostic accuracy and efficiency. At the same time, the continued
evolution of the IVDR is reshaping the diagnostics landscape. There is increased emphasis on robust performance evidence, strengthened post-market surveillance, and greater transparency across the supply chain. Sifin control antigens are compatible not only with Sifin antisera but also with the antisera you (probably) already have in your fridge in the laboratory. They are used to verify the agglutinability of anti- Salmonella or anti-Shigella test reagents and to incorporate a reliable quality control step during slide agglutination procedures.
www.bioconnections.co.uk
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
